It's over.
Ariad will likely be sold in the next 2-4 weeks. Sale price at least 25, possibly 40.
Why?
1. No news of AGM. Ariad investor relations (Kendra Adams) has written to me twice, promising a date for the proxy and AGM announcement, but there is still no announcement. Anyone who does not see this as fishy is smoking crack.
2. Harvey is out. Ahead of schedule. This means a deal is on the table, and he was the only thing holding it up.
3. BRIGA is BTD, 788 is probably focused on KRAS. HUGE. Big Pharma would die and go to heaven for this IP. They need it.
4. Assets, including Ariad, have a shelf life. Denner knows this, and he's no fool. MIT, Yale, Ichan. He has been well trained.
5. Clock is ticking. Denner has been in Ariad for 18 months, the drama with Harvey was taxing, and it's time to declare victory and move on.
6. Calm before the storm. Volume has been abysmal. Nobody with any sense wants to trade, and tute ownership is at a record 80%.
Hang on to your shares for dear life, and acquire more if you have any cash.
Glta
TC
"And their buying....the stairway....to heaven".
ReplyDeleteFor this, "Gotta whole lotta love"!!
I copied this and pasted it to the Yahoo Ariad Message Board. -- ariad_investor
ReplyDeleteYou had me at 25..as a stretch ...no way 40 in 2 to 4 weeks !! To get to 40 you have to be at 25 first maybe years end though!
ReplyDeleteQuestion: If a sale was imminent why 7 new job postings in the past week?
ReplyDeletehttps://twitter.com/ariadpharm
Its called business as usual !!
ReplyDeleteIf the positions are necessary, perhaps the new staff would become employees of the buyer. Not sure why a help wanted ad would signal no buy out...
ReplyDelete